0.9% Sodium Chloride Injection, USP 4. 71 5% Dextrose Injection, USP 4.58 5% Dextrose/ 0.9% NaCl Injection 4.62 5% Dextrose in Lactated Ringers 4.92 Plasma-Lyte ® 56/ 5% Dextrose Injection 5.03 5% Dextrose, 0.45% Sodium Chloride, 4.61 and 0.15% Potassium Chloride Injection Sodium Lactate Injection (M/ 6) 5.54 LEVAQUIN Injection Premix in Single-Use Flexible Containers: LEVAQUIN Injection is also supplied in flexible containers containing a premixed, ready-to-use levofloxacin solution in D5 W for single-use. The fill volume is either 50 or 100 mL for the 100 mL flexible container or 150 mL for the 150 mL container. NO FURTHER DILUTION OF THESE PREPARATIONS ARE NECESSARY. Consequently each 50 mL, 100 mL, and 150 mL premix flexible container already contains a dilute solution with the equivalent of 250 mg, 500 mg, and 750 mg of levofloxacin, respectively (5 mg/ mL) in 5% Dextrose (D5W). This parenteral drug product should be inspected visually for particulate matter prior to administration. Samples containing visible particles should be discarded. Since the premix flexible containers are for single-use only, any unused portion should be discarded. Since only limited data are available on the compatibility of levofloxacin intravenous injection with other intravenous substances, additives or other medications should not be added to LEVAQUIN Injection in flexible containers or infused simultaneously through the same intravenous line. If the same intravenous line is used for sequential infusion of several different drugs, the line should be flushed before and after infusion of LEVAQUIN Injection with an infusion solution compati-ble with LEVAQUIN Injection and with any other drug( s) administered via this common line. Instructions for the Use of LEVAQUIN Injection Premix in Flexible Containers To open: | ||||
Email this article
Printer friendly
Bookmark this pageadvertisement
